Giovanni Cosmi

Giovanni Cosmi is a Pharmaceutical Quality Management Systems professional with over 30 years’ experience gained working in Italy with several domestic and international companies such as Merrell Dow Pharmaceuticals, Bristol Myers-Squibb, and Pfizer. His last role was in Quality Operations Process Re-engineering, performing advising and Project Management in the Quality Operations area with the goal of promoting the efficacy of the company’s Continuous Improvement program.

Giovanni is a passionate advocate of Human Error Prevention and Quality Risk Management in the pharmaceutical industry. He firmly believes that, together with knowledge management, these are crucial enablers for achieving a positive impact on the quality, safety, and efficacy of medicines and, ultimately, on patients’ quality of life.

He earned his Degree in Chemistry with honors from Rome University in 1982. Additionally, he has been recognized as a Qualified Person by the Italian Agency for Drugs (AIFA 2004), is a registered auditor for the Rx-360 Consortium, and is qualified as an Auditor/Lead Auditor for ISO 22716:2007 Cosmetics – Good Manufacturing Practices (GMP) guideline.

During his career, Giovanni has acquired operational, strategic, and organizational skills to manage processes and human resources, building and maintaining Quality Management Systems (QMS) in compliance with cGMP requirements for companies operating in FDA and EMA environments.

He has taken part in and managed local cross-functional and international processes related to quality and management aspects. This experience has allowed him to deepen his knowledge of up-to-date manufacturing management methods (e.g., Lean Manufacturing) and Project Management.

With a focus on achieving continuous improvement in the quality area, Giovanni has completed significant projects in the definition of new organizational processes, process re-engineering, operational flexibility, integrated operational systems (e.g., SAP), and the reduction of standard and operating costs.

Currently, as a Senior Pharmaceutical Consultant, he collaborates with several international consulting companies in the pharmaceutical business. He provides expertise to realize Quality Systems, Education & Training programs, and Continuous Improvement Projects. His work supports the complex nature of pharmaceutical manufacturing by offering the foundation for Knowledge & Sharing Management processes.

These activities aim to ensure compliance with the three pillars of “quality, efficacy, and patient safety” in drug manufacturing while achieving efficiency in these processes, contributing to their growth and competitiveness.